MYMD Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease...

Stats
Dagens volum	36 918.00
Gjennomsnittsvolum	228 437
Markedsverdi	7.18M
EPS	$0 ( 2024-03-29 )
Neste inntjeningsdato	( $0 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.620
ATR14	$0.0310 (0.93%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-24	Rivard Paul	Buy	150 000	Common stock
2023-08-17	Rivard Paul	Buy	25 000	Common stock
2023-06-07	Chapman Christopher C Jr	Buy	300 000	Employee Stock Option (Right to Buy)
2023-06-07	Kaplin Adam	Buy	150 000	Employee Stock Option (Right to Buy)
2023-06-07	Uzonwanne Jude	Buy	150 000	Employee Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 84 transactions
Buy: 8 636 568 \| Sell: 532 775

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: -0.26 (neutral)

Signal:(59.659) Neutral

MyMD Pharmaceuticals, Korrelasjon

10 Mest positive korrelasjoner
TBLT	0.96
VRM	0.957
RIDE	0.956
FFIE	0.952
TENX	0.95
IRBT	0.948
CRCT	0.947
ENNV	0.947
OM	0.947
MSEX	0.947

10 Mest negative korrelasjoner
NVCN	-0.957
TIOA	-0.956
ADTH	-0.954
SILK	-0.953
MSDA	-0.952
VLAT	-0.952
ALOR	-0.948
TIOAU	-0.948
BRIVU	-0.946
BUFF	-0.944

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

MyMD Pharmaceuticals, Korrelasjon - Valuta/Råvare

0.44
( neutral )

0.30
( neutral )

0.00
( neutral )

0.35
( neutral )

0.71
( moderate )

0.07
( neutral )

MyMD Pharmaceuticals, Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.59

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.59

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-11.68

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.850

Financial Reports:

No articles found.

MyMD Pharmaceuticals,

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.